Dendrophthoe falcata (L.f.) Ettingsh. and Dendrophthoe pentandra (L.) Miq.: A review of traditional medical uses, phytochemistry, pharmacology, toxicity, and applications

Front Pharmacol. 2023 Feb 2:14:1096379. doi: 10.3389/fphar.2023.1096379. eCollection 2023.

Abstract

Dendrophthoe falcata (L.f.) Ettingsh. (DF) and Dendrophthoe pentandra (L.) Miq. (DP) have been traditionally used for the treatment of various ailments, such as cancer, ulcers, asthma, paralysis, skin diseases, tuberculosis, and menstrual troubles, in the ethnomedicinal systems of India and Indonesia. Currently, the chemical structures of 46 compounds have been elucidated from DF and DP, including flavonoids, triterpenes, tannins, steroids, open-chain aliphatics, benzyl derivates, and cyclic chain derivatives. In vitro assays have revealed their anti-tumor and anti-microbial activities. In vivo studies have unraveled their pharmacological properties against tumors, depression, fertility disorders, inflammatory responses, and so on. Additionally, their weak toxicity to rats and brine shrimp, as well as their promising applications for pharmaceutical preparations and combined medication, were also revealed. Herein, we not only recapitulated traditional medical uses, phytochemistry, pharmacology, toxicity, and applications of DF and DP but also discussed current research limitations and future perspectives, which are instructive for those interested in them and are committed to advancing parasitic plants to the Frontier of phytomedicine. We highlighted that DF and DP will become promising medical plants rather than being discarded as notorious pests, provided that more and deeper research is undertaken.

Keywords: Dendrophthoe falcata (L.f.) Ettingsh.; Dendrophthoe pentandra (L.) Miq; applications; pharmacology; phytochemistry; toxicity; traditional uses.

Publication types

  • Review

Grants and funding

This work was funded by the Project of the Shandong Province Key Research and Development Program (2021CXGC010511), the project of Shandong postgraduate education quality curriculum (SDYKC21051), and the innovation training program for college students of Shandong University of Traditional Chinese Medicine (202255).